AIM ImmunoTech, Inc. (AIM)
1.45
-0.04
(-2.68%)
USD |
NYAM |
Dec 10, 16:00
1.46
+0.01
(+0.69%)
After-Hours: 20:00
AIM ImmunoTech Free Cash Flow: -13.33M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Perspective Therapeutics, Inc. | -106.85M |
| Protalix Biotherapeutics, Inc. | -11.69M |
| Electromed, Inc. | 8.738M |
| Xtant Medical Holdings, Inc. | 5.123M |
| Armata Pharmaceuticals, Inc. | -27.43M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -5.079M |
| Cash from Investing (Quarterly) | 0.296M |
| Cash from Financing (Quarterly) | 6.654M |
| Free Cash Flow Per Share (Quarterly) | -2.426 |
| Free Cash Flow to Equity (Quarterly) | -4.612M |
| Free Cash Flow to Firm (Quarterly) | -4.931M |
| Free Cash Flow Yield | -49.82% |